blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1429749

EP1429749 - PREPARATION OF SUBMICRON SIZED NANOPARTICLES VIA DISPERSION AND SOLVENT OR LIQUID PHASE REMOVAL [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  24.02.2012
Database last updated on 22.11.2024
Most recent event   Tooltip24.02.2012Application deemed to be withdrawnpublished on 28.03.2012  [2012/13]
Applicant(s)For all designated states
Baxter International Inc.
One Baxter Parkway
Deerfield, Illinois 60015 / US
[N/P]
Former [2004/26]For all designated states
BAXTER INTERNATIONAL INC.
One Baxter Parkway
Deerfield, Illinois 60015 / US
Inventor(s)01 / BRYNJELSEN, Sean
4 Walnut Grove Ct.
Lake-In-The-Hills, IL 60156 / US
02 / STERNBERG, Shmuel
709 E. Lenox Lane
Palatine, IL 60067 / US
03 / DUNHAM, Andrew, J.
1939 West Bluff Court
Round Lake, IL 60073 / US
04 / DOTY, Mark, J.
610 Kenilworth
Grayslake, IL 60030 / US
05 / KIPP, James, E.
609 Hermosa Avenue
Wauconda, IL 60084 / US
06 / JAYSWAL, Nailesh
29 Meigs Court
Bensenville, IL 60106 / US
07 / NARAYANAN, Krishnaswamy
2721 Minot Lane
Waukesha, WI 53188 / US
 [2004/26]
Representative(s)Dee, Ian Mark
Potter Clarkson LLP The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
[N/P]
Former [2004/26]Dee, Ian Mark
Eric Potter Clarkson, Park View House, 58 The Ropewalk
Nottingham NG1 5DD / GB
Application number, filing date02773579.425.09.2002
[2004/26]
WO2002US30447
Priority number, dateUS2001096427326.09.2001         Original published format: US 964273
US2002018303526.06.2002         Original published format: US 183035
[2004/26]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03026611
Date:03.04.2003
Language:EN
[2003/14]
Type: A2 Application without search report 
No.:EP1429749
Date:23.06.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 03.04.2003 takes the place of the publication of the European patent application.
[2004/26]
Search report(s)International search report - published on:EP03.07.2003
ClassificationIPC:A61K9/51
[2004/26]
CPC:
A61K9/5169 (EP,US); A61K9/14 (US); A61K9/145 (EP,US);
A61K9/5192 (EP,US); B01J13/04 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/26]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:HERSTELLUNG VON NANOPARTIKELN IM SUBMIKROMETERBEREICH DURCH DISPERSION UND ENTZUG DES LÖSUNGSMITTELS ODER DER FLÜSSIGEN PHASE[2004/26]
English:PREPARATION OF SUBMICRON SIZED NANOPARTICLES VIA DISPERSION AND SOLVENT OR LIQUID PHASE REMOVAL[2004/26]
French:PREPARATION DE NANOPARTICULES SUBMICRONIQUES PAR DISPERSION ET ELIMINATION D'UN SOLVANT OU D'UNE PHASE LIQUIDE[2004/26]
Entry into regional phase26.03.2004National basic fee paid 
26.03.2004Designation fee(s) paid 
26.03.2004Examination fee paid 
Examination procedure21.04.2003Request for preliminary examination filed
International Preliminary Examining Authority: US
25.03.2004Amendment by applicant (claims and/or description)
26.03.2004Examination requested  [2004/26]
12.09.2005Despatch of a communication from the examining division (Time limit: M04)
17.01.2006Reply to a communication from the examining division
09.03.2007Despatch of a communication from the examining division (Time limit: M02)
11.05.2007Reply to a communication from the examining division
22.02.2008Date of oral proceedings
10.04.2008Despatch of communication that the application is refused, reason: substantive examination {1}
10.04.2008Minutes of oral proceedings despatched
28.03.2011Despatch of a communication from the examining division (Time limit: M02)
14.07.2011Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2012/13]
09.08.2011Application deemed to be withdrawn, date of legal effect  [2012/13]
Appeal following examination10.06.2008Appeal received No.  T1744/08
15.08.2008Statement of grounds filed
07.12.2010Result of appeal procedure: continuation of examination procedure
Divisional application(s)EP08075760.2  / EP2016938
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  12.09.2005
Fees paidRenewal fee
23.09.2004Renewal fee patent year 03
21.09.2005Renewal fee patent year 04
27.09.2006Renewal fee patent year 05
26.09.2007Renewal fee patent year 06
25.09.2008Renewal fee patent year 07
25.09.2009Renewal fee patent year 08
27.09.2010Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
30.09.201110   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO9420072  (PHARMACIA AB [SE], et al) [X] 35,36,38-41,45-51,56,60-63,65-69,71-74,80-85,88-94 * page 7, line 31 - line 33 * * page 9, line 1 - line 9 * * page 10, line 19 - line 21 * * page 13, line 11 * * page 14, line 14 - line 33 * * page 15, line 14 - page 17, line 26 * * page 18, line 10 - line 13 * * page 18, line 26 - page 19, line 1 * * page 19, line 13 * * examples 23,25-33 *;
 [X]WO9620698  (UNIV MICHIGAN [US], et al) [X] 1-5,8,10-20,24-30,32-38,41,45-50,52,60-80,82-87,89,91,92 * page 6, line 15 - page 7, line 16 * * page 9, line 5 - page 12, line 13 * * page 13, line 8 - page 14, line 2 * * page 15, line 1 - line 15 * * page 16, line 3 - page 17, line 9 * * page 18, line 8 - line 15 * * page 24, line 19 - page 25, line 6 * * page 20, line 7 - line 10 * * page 30, line 4 - line 9 * * page 30 - page 34; examples 1-3,110 * * page 36 - page 38; example 6 * * page 39; table 1 * * page 41, line 10 - page 42, line 14 * * page 43; table 2 * * page 74, line 13 - page 75, line 20 * * page 97, line 2 - page 98, line 4 * * page 99 - page 100; example 20 *;
 [X]WO9814174  (VIVORX PHARMACEUTICALS INC [US], et al) [X] 1-12,15,25-41,45-54,56,57,59-62,65-96 * page 1, line 2 - line 22 * * page 8, line 8 - line 31 * * page 9, line 19 - line 25 * * page 10, line 12 - line 35 * * page 12, line 15 - line 25 * * page 13, line 8 - line 9 * * page 14, line 13 - page 15, line 21 * * page 16, line 14 - line 21 * * page 17, line 13 - page 21, line 14 * * page 22, line 6 - page 28, line 37 * * page 30, line 3 - line 14 * * page 32, line 7 - line 18 * * examples 1-6,8-10,13,20,22,23 *;
 [X]WO9900113  (VIVORX PHARMACEUTICALS INC [US], et al) [X] 1-11,15,25-41,45-54,56,57,59-62,65-96 * page 1, line 10 - line 12 * * page 9, line 16 - line 26 * * page 11, line 1 - line 2 * * page 20, line 21 - page 22, line 2 * * page 23, line 30 - page 24, line 9 * * page 24, line 24 - line 27 * * page 27, line 1 - line 7 * * page 38, line 14 - page 46, line 16 * * page 48, line 1 - page 54, line 10 * * page 55, line 16 - page 56, line 26 * * examples 1-5,8,9,12-14,16,18,19 *;
 [X]US6139870  (VERRECCHIA THIERRY [FR]) [X] 35-41,45-51,56,60,61,63,67-77,80-85,87-95 * column 1, line 26 - line 55 * * column 1, line 65 - column 3, line 9 * * column 3, line 34 - line 44 * * examples 1-9 *;
 [A]  - SJÖSTRÖM B ET AL, "THE FORMATION OF SUBMICRON ORGANIC PARTICLES BY PRECIPITATION IN AN EMULSION", JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY, (1994), vol. 15, no. 1, pages 89 - 117, XP009002392 [A] 1-13,16-20,22,25-41,45-54,56-63,67,71-75,80-85,87-95 * page 91, line 10 - page 92, line 10 * * page 92; figure 1 * * page 95, line 6 - page 96, line 5 * * page 99, line 1 - line 3 * * page 101, line 1 - line 3 * * page 102, line 14 - line 20 *

DOI:   http://dx.doi.org/10.1080/01932699408943545
 [A]  - SJOSTROM B ET AL, "A METHOD FOR THE PREPARATION OF SUBMICRON PARTICLES OF SPARINGLY WATER-SOLUBLE DRUGS BY PRECIPITATION IN OIL-IN-WATER EMULSIONS. II: INFLUENCE OF THE EMULSIFIER, THE SOLVENT, AND THE DRUG SUBSTANCE", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN PHARMACEUTICAL ASSOCIATION. WASHINGTON, US, (19930601), vol. 82, no. 6, ISSN 0022-3549, pages 584 - 589, XP000367863 [A] 1-13,15-22,25-41,45-54,56-63,65-67,71-75,80-96 * page 584, column 2, paragraph 4 * * page 585, column 2, line 2 - line 14 * * page 585, column 2, line 31 - page 586, column 1, line 15 * * page 586, column 1, paragraph 5 - column 2, line 4 * * page 586; figure 2 * * page 587, column 1, paragraph 3 - paragraph 4 * * page 587; table II * * page 588, column 2, paragraph 2 * * page 589, column 1, line 3 - line 5 *

DOI:   http://dx.doi.org/10.1002/jps.2600820608
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.